Isabel Gameiro‐Ros

Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer’s disease

Isabel Gameiro‐Ros, Patrycja Michalska, Giammarco Tenti et al. · Scientific Reports · 2017 · 75 citations · Full text

Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models

Izaskun Buendía, Vanessa Gómez‐Rangel, Laura González‐Lafuente et al. · Neuropharmacology · 2015 · 40 citations

Neurophysiology, Medicine, Pharmacology +11

New Melatonin–Cinnamate Hybrids as Multi-Target Drugs for Neurodegenerative Diseases: Nrf2-Induction, Antioxidant Effect and Neuroprotection

Izaskun Buendía, Elisa Navarro, Patrycja Michalska et al. · Future Medicinal Chemistry · 2015 · 36 citations

Comparison of K+ Channel Families

Jaume Taura, Daniel M. Kircher, Isabel Gameiro‐Ros et al. · Handbook of experimental pharmacology · 2021 · 24 citations

Channel Modeling, Engineering, K+ Channel Families +2

Alcohol reverses the effects of KCNJ6 (GIRK2) noncoding variants on excitability of human glutamatergic neurons

Dina Popova, Isabel Gameiro‐Ros, Mark M. Youssef et al. · Molecular Psychiatry · 2022 · 19 citations · Full text

Synaptic Plasticity, Molecular Neuroscience, Human Glutamatergic Neurons +10